These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35073183)

  • 21. Differences and similarities in breast cancer risk assessment models in clinical practice: which model to choose?
    Jacobi CE; de Bock GH; Siegerink B; van Asperen CJ
    Breast Cancer Res Treat; 2009 May; 115(2):381-90. PubMed ID: 18516672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Compliance with screening recommendations according to breast cancer risk levels in Izmir, Turkey.
    Acikgoz A; Ergor G
    Asian Pac J Cancer Prev; 2013; 14(3):1737-42. PubMed ID: 23679266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting breast cancer risk in a racially diverse, community-based sample of potentially high-risk women.
    Meadows RJ; Figueroa W; Shane-Carson KP; Padamsee TJ
    Cancer Med; 2022 Nov; 11(21):4043-4052. PubMed ID: 35388639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast cancer risk prediction using Tyrer-Cuzick algorithm with an 18-SNPs polygenic risk score in a European population with below-average breast cancer incidence.
    Oblak T; Škerl P; Narang BJ; Blagus R; Krajc M; Novaković S; Žgajnar J
    Breast; 2023 Dec; 72():103590. PubMed ID: 37857130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank.
    Collister JA; Liu X; Littlejohns TJ; Cuzick J; Clifton L; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 2024 Jun; 33(6):812-820. PubMed ID: 38630597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants.
    Evans DGR; Harkness EF; Brentnall AR; van Veen EM; Astley SM; Byers H; Sampson S; Southworth J; Stavrinos P; Howell SJ; Maxwell AJ; Howell A; Newman WG; Cuzick J
    Breast Cancer Res Treat; 2019 Jul; 176(1):141-148. PubMed ID: 30941651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of an Educational Intervention on Women's Health Care Provider Knowledge Gaps About Breast Cancer Risk Model Use and High-risk Screening Recommendations.
    Seitzman RL; Pushkin J; Berg WA
    J Breast Imaging; 2023 Feb; 5(1):30-39. PubMed ID: 38416962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Personalized survivorship care: Routine breast cancer risk assessment in the gynecologic oncology clinic.
    Ahsan MD; Webster EM; Wolfe IA; McGonigle R; Brewer JT; Chandler IR; Weiss JM; Enriquez A; Cantillo E; Holcomb K; Chapman-Davis E; Blank SV; Sharaf RN; Frey MK
    Gynecol Oncol; 2024 Apr; 183():47-52. PubMed ID: 38503141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive Breast Cancer Risk Assessment for
    Gallagher S; Hughes E; Kurian AW; Domchek SM; Garber J; Probst B; Morris B; Tshiaba P; Meek S; Rosenthal E; Roa B; Slavin TP; Wagner S; Weitzel J; Gutin A; Lanchbury JS; Robson M
    JCO Precis Oncol; 2021 Jun; 5():. PubMed ID: 34322652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Customized breast cancer risk assessment in an ambulatory clinic: a portal for identifying women at risk.
    Weiss A; Grossmith S; Cutts D; Mikami SA; Suskin JA; Graichen MK; Rojas NA; Pace LE; Joyce E; Rhei E; Scheib R; Bychkovsky B; Garber JE; Morganstern D; King TA
    Breast Cancer Res Treat; 2019 May; 175(1):229-237. PubMed ID: 30666540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimating the Cost of 3 Risk Prediction Strategies for Potential Use in the United Kingdom National Breast Screening Program.
    Wright SJ; Eden M; Ruane H; Byers H; Evans DG; Harvie M; Howell SJ; Howell A; French D; Payne K
    MDM Policy Pract; 2023; 8(1):23814683231171363. PubMed ID: 37152662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-Term Performance of an Image-Based Short-Term Risk Model for Breast Cancer.
    Eriksson M; Czene K; Vachon C; Conant EF; Hall P
    J Clin Oncol; 2023 May; 41(14):2536-2545. PubMed ID: 36930854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An alternative approach to selecting patients for high-risk screening with breast MRI.
    Hollingsworth AB; Stough RG
    Breast J; 2014; 20(2):192-7. PubMed ID: 24387050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accuracy of the Breast Cancer Surveillance Consortium Model Among Women with LCIS.
    Eroglu I; Sevilimedu V; Park A; King TA; Pilewskie ML
    Breast Cancer Res Treat; 2022 Jul; 194(2):257-264. PubMed ID: 35595928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case-control evaluation of 143 single nucleotide polymorphisms for breast cancer risk stratification with classical factors and mammographic density.
    Brentnall AR; van Veen EM; Harkness EF; Rafiq S; Byers H; Astley SM; Sampson S; Howell A; Newman WG; Cuzick J; Evans DGR
    Int J Cancer; 2020 Apr; 146(8):2122-2129. PubMed ID: 31251818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An integrated breast cancer risk assessment and management model based on fuzzy cognitive maps.
    Subramanian J; Karmegam A; Papageorgiou E; Papandrianos N; Vasukie A
    Comput Methods Programs Biomed; 2015 Mar; 118(3):280-97. PubMed ID: 25697987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Pre-Test-Post-Test Trial of a Breast Cancer Risk Report for Women in Their 40s.
    Schonberg MA; Davis RB; Karamourtopoulos MC; Pinheiro A; Sternberg SB; Jacobson AR; Aliberti GM; Mehta TS; Cluett JL; Cohen ML; Atlas T; Tung NM
    Am J Prev Med; 2020 Sep; 59(3):343-354. PubMed ID: 32828322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utilization of breast cancer screening with magnetic resonance imaging in community practice.
    Hill DA; Haas JS; Wellman R; Hubbard RA; Lee CI; Alford-Teaster J; Wernli KJ; Henderson LM; Stout NK; Tosteson ANA; Kerlikowske K; Onega T
    J Gen Intern Med; 2018 Mar; 33(3):275-283. PubMed ID: 29214373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance.
    Quante AS; Whittemore AS; Shriver T; Strauch K; Terry MB
    Breast Cancer Res; 2012 Nov; 14(6):R144. PubMed ID: 23127309
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.